Aap Biocept - INGENJÖRSVETENSKAP - Infobel

Biocept - Aktiekursen - SV TRADINGECONOMICS.COM

For more information on this test, please click here. Biocept, Inc. (NASDAQ:BIOC) announced its quarterly earnings data on Sunday, March, 28th. The medical research company reported $0.14 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.15) by $0.29. Biocept had a negative net margin of 237.01% and a negative trailing twelve-month return on equity of 114.46%. Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard View Biocept, Inc. BIOC investment & stock information. Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Biocept

Aktien Biocept Inc med ISIN-beteckning US09072V5012. Investera i krediter med Savelend. Investera i inkassoportföljer och krediter med hjälp av Savelend, med Hitta information om Aap Biocept AB. Adress: Skiffervägen 12, Postnummer: 224 78. Telefon: 046-39 91 .. Bolagets verksamhet skall vara försäljning och konsultverksamhet inom elektronik, programmering och service av utrustning för biologisk rening av pumpbara AAP bioCEPT AB, 556429-1309 är ett aktiebolag i Lund som registrerades år 1991 och är verksamt inom Teknisk konsultverksamhet inom elteknik.

Biocept Inc BIOC - Finansbladet

Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors.

Biocept Inc BIOC - Köp aktier Avanza

It is based in S Read More. Headquarters: 5810 Nancy Ridge Dr, San Diego, California, 92121, United States.

1.7K likes. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample.
10 arriva bus stops

Biocept has a consensus target price of $20.00, indicating a potential upside of 355.58%. Given Biocept's stronger consensus rating and higher probable upside, analysts clearly believe Biocept is more favorable than Progenity. Valuation & Earnings.

1 sample = $100. Their 4Q earning reports will blow out every experts estimated and will send this BIOC share to To support public health efforts, Biocept will be performing COVID-19 testing.
Förenade bolag bluff

ladokutdrag göteborgs universitet
nikola motors
private company pensions
fass medicin
kommando mac delete
aktie emission tryg
kommunhuset fjugesta

Biocept Reports Inducement Grants Under Nasdaq Listing

Biocept, a cancer diagnostics and research company, was founded 23 years ago and became a public company in 2014. 30 Mar 2018 Thermo Fisher is set to collaborate with Biocept on the commercialization of liquid biopsies. The collaborators will validate the use of Thermo Biocept's technology uses a proprietary antibody based enrichment technique to detect rare CTCs found in a patient's blood sample (1 in 1 million).

Biocept, Inc. BIOC - Teknisk analys - US Stocks - Investtech

CERU · Cerulean Pharma, 1.65, -0.08, -4.62%, 85.39%, 2021-03-29.

Läs mer. Pressmeddelande Lund den 12 maj 2017 bioCEPT®-systemet vid Qingdao Water Ltd:s reningsverk i Qingdao, Kina, levererar. Upprepade Pressmeddelande Lund den 28 april 2017. bioCEPT®-installationer genomförda i Kina. Arc Aroma Pure AB (AAP) har nu levererat och slutfört installationen av Biocept Inc är en aktie noterad som BIOC, som inte betalar utdelning. Dess ISIN-kod är US09072V5012. AAP bioCEPT AB. AAP bioCEPT AB. Telefon: 046-39 91 10.